Prophylactic phenylephrine bolus to prevent hypotension after CSE underwent cesarean section

The prognosis and prevention of hypotension after CSE underwent cesarean section

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026053

Enrollment

Unknown

Registered

2019-09-19

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension after CSE during cesarean setion

Interventions

Prophylactic group:use phenylephrine

Eligibility

Sex/Gender

Male

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Aged 18-40 years, with a full-term ( >37-weeks gestation) singleton pregnancy, ASA score II, and undergoing an elective CD.

Exclusion criteria

Exclusion criteria: Exclusion criteria for the study were as follows: allergy to phenylephrine, preexisting or pregnancy-induced hypertension, preeclampsia, cardiovascular or cerebrovascular disease, fetal distress or fetal abnormalities, multiple gestations, patient refusal.

Design outcomes

Primary

Measure	Time frame
Blood pressure;heart rate;syptom of hypotension;situation of neonates;key time;effect of CSE;	—

Countries

China

Contacts

Public ContactTao Xu

Department of Anesthesiology, the International Peace Maternity and Child Health Hospital, Shanghai Jiaotong University School of Medicine

towerxutao@163.com+86 18918098660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026